Photo from wikipedia
before treatment, which can lead to lower detection by HLC. However, this study confirms that HLC is a useful biomarker to detect and to follow the monoclonal component in either… Click to show full abstract
before treatment, which can lead to lower detection by HLC. However, this study confirms that HLC is a useful biomarker to detect and to follow the monoclonal component in either primary or secondary agglutinin disease.
Keywords:
agglutinin disease;
heavy chain;
useful biomarker;
chain
Journal Title: British Journal of Haematology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Haematology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!